- Home
- NYT vs BRKR Comparison
NYT vs BRKR Comparison
Compare NYT & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NYT | BRKR |
|---|---|---|
| Founded | 1851 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Newspapers/Magazines | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 7.0B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | NYT | BRKR |
|---|---|---|
| Price | $71.01 | $48.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $65.33 | $49.42 |
| AVG Volume (30 Days) | 1.9M | ★ 2.1M |
| Earning Date | 02-04-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.01% | 0.42% |
| EPS Growth | ★ 21.46 | N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | $2,722,033,000.00 | ★ $3,438,900,000.00 |
| Revenue This Year | $11.06 | $3.55 |
| Revenue Next Year | $6.93 | $1.49 |
| P/E Ratio | $34.61 | ★ N/A |
| Revenue Growth | ★ 8.49 | 6.10 |
| 52 Week Low | $44.83 | $28.53 |
| 52 Week High | $71.23 | $64.64 |
Technical Indicators
Market Signals| Indicator | NYT | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 76.03 | 60.92 |
| Support Level | $70.30 | $44.11 |
| Resistance Level | $71.07 | $49.15 |
| Average True Range (ATR) | 1.23 | 1.76 |
| MACD | 0.21 | -0.08 |
| Stochastic Oscillator | 96.97 | 79.57 |
Price Performance
Historical ComparisonAbout NYT New York Times Company (The)
New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.